Latest Breaking News On - Phil nadeau - Page 5 : vimarsana.com

Myovant Sciences Ltd. (MYOV) Q1 2022 Earnings Call Transcript

MYOV earnings call for the period ending June 30, 2022.

Biogen (BIIB) Q2 2022 Earnings Call Transcript

BIIB earnings call for the period ending June 30, 2022.

Betting on Biotech Bear Market Expiration Date

Since last year, biotechnology stocks and exchange traded funds have been among the most disappointing equity assets.

Eileen Fair: Diversity programs resolution reflects white male privilege

Myovant Sciences Ltd. (MYOV) Q4 2021 Earnings Call Transcript

MYOV earnings call for the period ending March 31, 2022.

Vertex Pharmaceuticals (VRTX) Q1 2022 Earnings Call Transcript

VRTX earnings call for the period ending March 31, 2022.

Vertex Pharmaceuticals Incorporated (VRTX) CEO Dr. Reshma Kewalramani on Q1 2022 Results - Earnings Call Transcript

Vertex Pharmaceuticals Incorporated (NASDAQ:NASDAQ:VRTX) Q1 2022 Earnings Conference Call May 05, 2022 4:30 PM ET Company Participants Michael Partridge - SVP of IR Reshma Kewalramani -...

Dynavax Technologies (DVAX) Q1 2022 Earnings Call Transcript

DVAX earnings call for the period ending March 31, 2022.

Galapagos NV (GLPG) CEO Paul Stoffels on Q1 2022 Results - Earnings Call Transcript

Galapagos NV (NASDAQ:NASDAQ:GLPG) Q1 2022 Results Conference Call May 6, 2022 08:00 AM ET Company Participants Sofie Van Gijsel - Senior Director, Investor Relations Paul Stoffels - Chief...

Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q1 2022 Results - Earnings Call Transcript

Neurocrine Biosciences, Inc. (NASDAQ:NASDAQ:NBIX) Q1 2022 Earnings Conference Call May 04, 2022, 08:00 ET Company Participants Todd Tushla - VP, IR Kevin Gorman - CEO & Director Matthew...